101 related articles for article (PubMed ID: 9722825)
1. What we have learned from research about the prevention of HIV transmission among drug abusers.
Sloboda Z
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):194-204. PubMed ID: 9722825
[TBL] [Abstract][Full Text] [Related]
2. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
Coyle SL; Needle RH; Normand J
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):19-30. PubMed ID: 9722807
[TBL] [Abstract][Full Text] [Related]
3. Designing interventions to prevent HIV-1 infection by promoting use of condoms and spermicides among intravenous drug abusers and their sexual partners.
Stone AJ; Morisky D; Detels R; Braxton H
AIDS Educ Prev; 1989; 1(3):171-83. PubMed ID: 2641239
[TBL] [Abstract][Full Text] [Related]
4. HIV/AIDS risks among Native American drug users: key findings from focus group interviews and implications for intervention strategies.
Baldwin JA; Trotter RT; Martinez D; Stevens SJ; John D; Brems C
AIDS Educ Prev; 1999 Aug; 11(4):279-92. PubMed ID: 10494353
[TBL] [Abstract][Full Text] [Related]
5. Cocaine use and HIV risk in out of treatment drug abusers.
Compton WM
Drug Alcohol Depend; 2000 Mar; 58(3):215-8. PubMed ID: 10759031
[TBL] [Abstract][Full Text] [Related]
6. Community prevention efforts to reduce the spread of AIDS associated with intravenous drug abuse.
Leukefeld CG; Battjes RJ; Amsel Z
AIDS Educ Prev; 1990; 2(3):235-43. PubMed ID: 2265061
[TBL] [Abstract][Full Text] [Related]
7. Drug abuse treatment as AIDS prevention.
Metzger DS; Navaline H; Woody GE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):97-106. PubMed ID: 9722815
[TBL] [Abstract][Full Text] [Related]
8. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
9. Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users.
Purcell DW; Garfein RS; Latka MH; Thiede H; Hudson S; Bonner S; Golub ET; Ouellet LJ;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S73-80. PubMed ID: 17466465
[TBL] [Abstract][Full Text] [Related]
10. HIV prevention and psychoactive drug use: a research agenda.
Des Jarlais DC; Semaan S
J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
[TBL] [Abstract][Full Text] [Related]
11. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
Kretzschmar M; Wiessing L
AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
[TBL] [Abstract][Full Text] [Related]
12. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
13. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
Donoghoe MC; Verster A; Pervilhac C; Williams P
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
[TBL] [Abstract][Full Text] [Related]
14. HIV prevention in clinical practice.
Coates TJ
AIDS Clin Care; 1999 Jan; 11(1):1-2, 8. PubMed ID: 11366094
[TBL] [Abstract][Full Text] [Related]
15. Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS.
Bryant KJ
Subst Use Misuse; 2006; 41(10-12):1465-507. PubMed ID: 17002990
[TBL] [Abstract][Full Text] [Related]
16. Bloodborne and sexually transmitted infections in drug abusers in the United States, Latin America, the Caribbean, and Spain.
Khalsa JH; Francis H; Mazin R
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S331-7. PubMed ID: 14648442
[TBL] [Abstract][Full Text] [Related]
17. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
Kalichman SC
Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
[TBL] [Abstract][Full Text] [Related]
18. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
Garfein RS; Golub ET; Greenberg AE; Hagan H; Hanson DL; Hudson SM; Kapadia F; Latka MH; Ouellet LJ; Purcell DW; Strathdee SA; Thiede H;
AIDS; 2007 Sep; 21(14):1923-32. PubMed ID: 17721100
[TBL] [Abstract][Full Text] [Related]
19. Principles of harm reduction. Harm Reduction Coalition.
Newsline People AIDS Coalit N Y; 1998 Jun; ():7-8. PubMed ID: 11367472
[TBL] [Abstract][Full Text] [Related]
20. HIV risk behavioral surveillance: a methodology for monitoring behavioral trends.
Mills S; Saidel T; Bennett A; Rehle T; Hogle J; Brown T; Magnani R
AIDS; 1998; 12 Suppl 2():S37-46. PubMed ID: 9792360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
